Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

kidneycancer

3 months
28 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Leigh Ellis Department of Oncologic Pathology Dana-Farber Cancer Institute Harvard Medical School presents Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Up Next Autoplay